Guidelines for Authors

Author Guidelines

1. Journal Scope

Bioinnovati is an international academic journal dedicated to the publication of original, high-quality, and ethically sound contributions in the life sciences, innovation, and applied interdisciplinary research. The journal welcomes manuscripts that advance knowledge, methods, technologies, and evidence-based practice in areas including, but not limited to:

  • biotechnology and biological innovation;
  • agricultural and animal sciences;
  • food science, nutrition, and food safety;
  • environmental sciences and sustainability;
  • veterinary and health-related sciences;
  • natural resources and ecosystem studies;
  • microbiology, molecular biology, and genetics;
  • bioinformatics, computational biology, omics data analysis, and systems biology;
  • education, research methodology, and scientific innovation;
  • technology transfer, applied development, and interdisciplinary scientific solutions.

Bioinnovati prioritizes submissions that demonstrate scientific rigor, methodological transparency, relevance, originality, and reproducibility. This scope statement is consistent with the broader structure of the submission guides you provided, while extending them to include bioinformatics and computational research as an explicit area of interest.

2. Types of Manuscripts

Bioinnovati accepts the following categories of submissions:

2.1 Original Research Articles

Original Research Articles must present scientifically sound and reproducible research, provide a substantial contribution to knowledge, and cite the most relevant recent literature. These manuscripts should normally include: Abstract, Keywords, Introduction, Materials and Methods, Results, Discussion, and, where appropriate, Conclusions.

2.2 Review Articles

Review Articles should provide a comprehensive, critical, and constructive synthesis of the literature in a defined field. Reviews should identify current gaps, unresolved issues, and future directions. They must not present unpublished primary data as original findings.

2.3 Systematic Reviews and Meta-Analyses

Systematic Reviews and Meta-Analyses should follow the structure of a research article and comply with recognized reporting standards such as PRISMA. Authors are strongly encouraged to provide the relevant checklist and flow diagram and to report protocol registration when available.

2.4 Scoping Reviews

Scoping Reviews may be submitted as Review Articles and should follow the PRISMA extension for scoping reviews. Authors are encouraged to register protocols in an appropriate public registry before data extraction begins.

2.5 Short Communications or Technical Notes

These submissions report brief but important methodological advances, preliminary findings, technical innovations, software tools, datasets, protocols, or focused scientific observations of immediate interest.

2.6 Case Studies or Applied Reports

Bioinnovati may consider case-based or applied contributions when they offer a clear scientific, methodological, or technical contribution and are supported by sufficient evidence.

The Editorial Board reserves the right to determine the most appropriate article category for any submission.

3. General Submission Requirements

All manuscripts submitted to Bioinnovati must satisfy the following conditions:

  • the work must be original and must not have been previously published or be under consideration elsewhere, in whole or in part;
  • all authors must have read and approved the submitted version of the manuscript;
  • all listed authors must meet accepted authorship criteria and must have made substantial scholarly contributions;
  • the manuscript must be written in clear, precise, and grammatically correct English;
  • authors must disclose all relevant funding sources, conflicts of interest, and ethics approvals when applicable.

Bioinnovati may accept free-format initial submissions, provided that all required scientific and ethical components are included. Once a manuscript reaches the revision or acceptance stage, authors may be asked to format the paper according to the journal template.

4. Publication Ethics

Bioinnovati is committed to maintaining the integrity of the scientific record and follows internationally accepted principles of publication ethics.

4.1 Originality and Plagiarism

Manuscripts must be original. Plagiarism, self-plagiarism, unattributed reuse, and duplicate publication are unacceptable. Submitted manuscripts may be screened with similarity-detection software, and suspected cases will be investigated according to editorial ethics procedures.

4.2 Redundant or Duplicate Submission

Authors must not submit the same or substantially similar manuscripts to more than one journal at the same time. Redundant publication and fragmented publication practices are not permitted.

4.3 Citation Manipulation

Citations must be included only for scholarly relevance. Inappropriate citation intended to inflate citation metrics is considered unethical.

4.4 Authorship Integrity

Guest, gift, and ghost authorship are unacceptable. Only individuals who made substantial contributions to the conception, design, execution, analysis, interpretation, drafting, or critical revision of the work may be listed as authors.

4.5 Conflicts of Interest

All authors must disclose any financial, personal, institutional, or professional relationships that could influence, or appear to influence, the interpretation of the work. If no conflicts exist, authors should state: “The authors declare no conflict of interest.”

4.6 Corrections and Retractions

If serious errors or ethical concerns are identified after publication, the journal may publish corrections, expressions of concern, or retractions, depending on the severity and nature of the issue.

5. Authorship and Author Information

Each author must have made a substantial contribution to the manuscript and must accept responsibility for the integrity of the work. Bioinnovati recommends the use of a contribution statement based on the CRediT taxonomy, such as: Conceptualization, Methodology, Software, Validation, Formal Analysis, Investigation, Resources, Data Curation, Writing – Original Draft Preparation, Writing – Review & Editing, Visualization, Supervision, Project Administration, and Funding Acquisition.

At least one author must be designated as the Corresponding Author, who is responsible for communication with the journal during submission, review, revision, and proofing.

Authors should provide:

  • full names;
  • institutional affiliations;
  • city, postal code, and country;
  • email address for the corresponding author;
  • ORCID identifier, where available.

If an author is not affiliated with an institution, the affiliation may be listed as Independent Researcher.

6. Copyright, Licensing, and Digital Preservation

Bioinnovati publishes under an open-access model. Unless otherwise specified by the journal, authors retain copyright and published content is distributed under the Creative Commons Attribution License (CC BY), which allows reuse, distribution, and reproduction provided that the original work is properly cited.

The journal should also maintain a policy for long-term digital preservation and archiving to ensure continued access to published material. The source policy you provided emphasizes permanent digital preservation as an essential part of open-access publishing.

7. Submission Process

Manuscripts must be submitted through the journal’s official online submission system. The submitting author is generally the corresponding author and is responsible for ensuring that all eligible co-authors are included and that all authors have approved the submitted version.

A cover letter is required for each submission. It should briefly explain:

  • the significance of the work;
  • its originality;
  • its relevance to the scope of Bioinnovati;
  • confirmation that the manuscript is not under review elsewhere;
  • confirmation that all authors approve the submission.

8. Accepted File Formats

Bioinnovati encourages the submission of manuscripts in Microsoft Word or LaTeX. For Word submissions, authors should provide a single editable file. For LaTeX submissions, authors should provide a ZIP folder containing the manuscript source files, bibliography, and all figures. Supplementary files may be submitted in additional common formats.

Editable equations should be created using standard equation editors rather than inserted as images.

9. Manuscript Structure

9.1 Front Matter

All manuscripts should include:

  • Title
  • Author list
  • Affiliations
  • Corresponding author information
  • Abstract
  • Keywords

9.2 Research Articles

Research Articles should normally include:

  • Introduction
  • Materials and Methods
  • Results
  • Discussion
  • Conclusions, if appropriate

9.3 Back Matter

The back matter should include, where applicable:

  • Supplementary Materials
  • Author Contributions
  • Funding
  • Institutional Review Board Statement
  • Informed Consent Statement, when relevant
  • Data Availability Statement
  • Acknowledgments
  • Conflicts of Interest
  • References

This structure reflects the more complete manuscript preparation guide you shared.

10. Title, Abstract, and Keywords

10.1 Title

The title must be concise, specific, informative, and directly relevant to the work. It should accurately identify the nature of the study. For example, authors should indicate when the manuscript is a systematic review, meta-analysis, or trial-based study.

10.2 Abstract

The abstract should be a single paragraph of approximately 200 to 300 words, unless otherwise specified by the journal. It should briefly cover the background, objective, methods, main results, and principal conclusion. It should not include citations, equations, or unsupported claims.

10.3 Keywords

Authors should provide 3 to 10 keywords after the abstract. Keywords should be specific, accurate, and useful for indexing.

11. Main Text Requirements

11.1 Introduction

The Introduction should place the study in context, explain its significance, identify the knowledge gap, state the objectives clearly, and, where relevant, define the hypotheses being tested.

11.2 Materials and Methods

Methods must be described in enough detail to permit replication. New methods should be explained fully, while established methods may be cited appropriately. Authors must identify software name and version, and should indicate whether code is available. If generative AI tools were used for substantive drafting, data analysis, graphics generation, or related activities, that use should be transparently disclosed in this section or in the acknowledgments, as appropriate.

11.3 Results

Results must be presented clearly and concisely, without unnecessary repetition between text, tables, and figures. Statistical analyses, effect estimates, and relevant outputs should be reported transparently.

11.4 Discussion

The Discussion should interpret the findings in light of previous literature, address the study’s implications, highlight limitations, and propose future directions when relevant. Results and Discussion may be combined only when justified by the nature of the manuscript.

11.5 Conclusions

A Conclusions section is optional but recommended when the manuscript is lengthy or the Discussion is complex. Conclusions must be directly supported by the findings.

12. Ethical Statements for Human and Animal Research

Studies involving humans must state that the work was conducted in accordance with relevant ethical standards and, where applicable, the Declaration of Helsinki, with approval by an Institutional Review Board or Ethics Committee. Informed consent must also be reported when applicable.

Studies involving animals must identify the approving ethics body or state the applicable institutional or national animal welfare framework followed.

If ethical review was waived, authors must provide a clear justification. If the study did not involve humans or animals, authors may state “Not applicable.”

13. Data Availability, Reproducibility, and Open Science

Bioinnovati strongly encourages authors to make their materials, protocols, data, code, and workflows available in ways that support reproducibility and reuse. The guide you shared explicitly emphasizes that publication implies making materials, data, and protocols available wherever possible, while disclosing any justified restrictions.

All manuscripts should include a Data Availability Statement indicating where the supporting data can be found. Acceptable statements may include:

  • data openly available in a public repository;
  • data available upon reasonable request;
  • restricted access due to privacy, legal, ethical, or commercial reasons;
  • no new data generated;
  • data included within the article or supplementary material.

Authors are encouraged to deposit datasets in trusted repositories that provide persistent identifiers such as DOIs and permit long-term access.

14. Bioinformatics, Computational Research, Code, and Sequence Data

Because Bioinnovati includes bioinformatics and computational biology within its scope, manuscripts in these areas must meet heightened transparency and reproducibility standards.

Authors must:

  • report the names, versions, providers, and parameters of all software, pipelines, and analysis tools used;
  • deposit novel code, scripts, workflows, or software in a recognized public repository when possible, or provide them as supplementary material;
  • provide accession numbers for RNA, DNA, protein sequences, and other deposited molecular data in the manuscript;
  • deposit new nucleotide sequence data in recognized repositories such as GenBank, EMBL, or DDBJ before publication;
  • deposit new high-throughput sequencing datasets, such as RNA-seq or related omics datasets, in appropriate repositories such as GEO or SRA;
  • describe preprocessing steps, normalization, quality-control criteria, filtering thresholds, statistical workflows, and validation procedures clearly enough to allow reproduction.

For computational studies, authors are strongly encouraged to provide workflow diagrams, repository links, and version-controlled code records.

15. Supplementary Materials

Supplementary materials may include figures, tables, spreadsheets, datasets, videos, protocols, code, appendices, and other supporting documents. These files should be clearly labeled, for example: Figure S1, Table S1, Dataset S1, or Code S1. Supplementary files may be provided in any widely accessible format, but common, non-proprietary formats are preferred.

Any citations appearing in supplementary materials must also appear in the main reference list.

16. Tables, Figures, and Graphical Abstracts

Tables and figures should appear close to their first citation in the text and must be numbered consecutively. Tables must have clear headings, and figures must include complete captions explaining all symbols, abbreviations, and units.

Figures should be high quality. The more complete guide you provided recommends high-resolution files, preferably 600 dpi in PNG, JPEG, or TIFF format, while the earlier guide indicates that at minimum low-resolution images are not acceptable and figures should generally be at least 300 dpi.

Bioinnovati may also accept graphical abstracts. If submitted, they should be original, unpublished, visually clear, and not merely a duplicate of a figure from the main text.

17. Image Integrity

When images are central to the results, authors may be asked to provide original, uncropped, and unprocessed files. Image adjustments must be minimal, applied uniformly, and must not alter the scientific meaning of the data. Cropping, splicing, or reuse of control images must be transparently disclosed in the figure legend and, where needed, in the Methods section. These expectations are based on the detailed image-integrity guidance in the uploaded material.

18. References and Citation Style

References must be accurate, complete, and consistent. The more detailed guide you provided uses a numbered citation system, with references listed in order of appearance and cited in square brackets within the text. Bioinnovati may adopt this numbered style for consistency.

Authors should use reference-management software whenever possible. Full bibliographic details should be included for journal articles, books, book chapters, conference proceedings, theses, websites, datasets, and unpublished materials when appropriately cited.

19. Funding, Acknowledgments, and Author Contributions

All sources of financial support must be disclosed clearly. If no external funding was received, authors should state: “This research received no external funding.”

The Acknowledgments section may recognize administrative, technical, or in-kind support not qualifying for authorship. If generative AI tools were used for substantial tasks such as generating text, graphics, or analysis assistance, their use should be transparently acknowledged, and the authors remain fully responsible for the final content.

A detailed Author Contributions statement is required for multi-author submissions.

20. Peer Review and Post-Acceptance

All submissions undergo editorial screening and peer review. Manuscripts may be rejected before external review if they fall outside the scope of the journal, fail to meet quality standards, or do not comply with the author guidelines. The earlier guide you provided states that all manuscripts undergo extensive evaluation during peer review.

After acceptance, authors may be asked to submit a final journal-formatted version. Proof corrections should be limited to essential errors only. Substantive changes at proof stage are not normally permitted.

21. Final Declaration Required at Submission

By submitting a manuscript to Bioinnovati, the corresponding author confirms that:

  • the manuscript is original and not under consideration elsewhere;
  • all authors meet authorship criteria and approve the submission;
  • all ethical requirements have been met;
  • all conflicts of interest and funding sources have been declared;
  • all data, code, sequences, and materials have been reported as required;
  • all references are accurate and complete.